Decheng Capital LLC

Q1 2025 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    27

  • Value ($000)

    $356,489

  • Date Filed
    05/07/2025
  • Form type
    13F-HR
  • CIK
    0002010850
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
CGON
CGON

CG ONCOLOGY INC

COM
156944100
$156.04M
44 %

6,371,669

NUVB
NUVB

Nuvation Bio Inc.

COM
67080N101
$45.68M
13 %

25,954,439

---

AARDVARK THERAPEUTICS INC

COM
002942100
$29.42M
8 %

3,917,299

---

Upstream Bio Inc.

COM
91678A107
$20.11M
6 %

3,285,293

---

NEWAMSTERDAM PHARMA CO NV

COM
N62509109
$15.76M
4 %

770,000

KRYS
KRYS

KRYSTAL BIOTECH INC

COM
501147102
$11.72M
3 %

65,000

RVMD
RVMD

REVOLUTION MEDICINES INC(NSM)

COM
76155X100
$7.99M
2 %

226,000

---

MERUS NV

COM
N5749R100
$7.96M
2 %

189,098

---

BeyondSpring Inc.

SHS
G10830100
$6.97M
2 %

4,882,651

---

MOONLAKE IMMUNOTHERAPEUTICS

COM
G4444C102
$6.70M
2 %

171,600

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 27